EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer.
Almstedt K, Mendoza S, Otto M, Battista MJ, Steetskamp J, Heimes AS, Krajnak S, Poplawski A, Gerhold-Ay A, Hasenburg A, Denkert C, Schmidt M.
Almstedt K, et al. Among authors: poplawski a.
Breast Cancer Res Treat. 2020 Jul;182(1):137-146. doi: 10.1007/s10549-020-05688-1. Epub 2020 May 20.
Breast Cancer Res Treat. 2020.
PMID: 32436145
Free PMC article.